Recognizing Scientific Excellence and Originality in the Proceedings of the National Academy of Sciences

Published in PNAS, "Evidence for α-Synuclein Prions Causing Multiple System Atrophy in Humans with Parkinsonism" has been awarded the 2015 Cozzarelli Prize by the National Academy of Sciences. The Cozzarelli Prize is given annually to six papers published in PNAS and recognizes work that demonstrates scientific excellence and originality. Authored by Stanley B. Prusiner, Amanda L. Woerman, Kurt Giles, and colleagues in the IND, the paper... Read more ...

Did you get your copy yet?

Madness and Memory is now out on paperback and audiobook. The paperback is available at Amazon, Barnes & Noble, IndieBound, Yale University Press, and other online retailers, or if you prefer to listen or are a subscriber, get the audiobook at Audible—released today!

... Read more ...

Dr. Bruce Miller. Photo by Elisabeth Fall

Dr. Miller, director of the Memory and Aging Center, to codirect the new Global Brain Health Institute

Dr. Bruce Miller, the A.W. and Mary Margaret Clausen Distinguished Professorship in Neurology at UCSF, has been chosen to codirect the new Global Brain Health Institute (GBHI), a venture between UCSF and Trinity College Dublin.

Read more about Dr. Miller and the GBHI in the UCSF news feature "One neuroscientist's quest to create healthier brains."

Compound restores transparency to mouse lenses, human lens tissue

By Pete Farley (UCSF News) on November 5, 2015

A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists from UC San Francisco (UCSF), the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).

Identified as a “priority eye disease” by the World Health Organization, cataracts—caused when the lenses of the eyes lose their transparency—affect more than 20 million people worldwide. Although cataracts can be successfully removed with surgery, this approach is expensive, and most individuals blinded by severe cataracts in developing countries go untreated.

Reported November 5 in Science, the newly identified compound is the first that is soluble enough to potentially form the basis of a... Read more ...